Remedent, Inc. (REMI)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
At close: Sep 9, 2026
Remedent Market Cap
Remedent has a market cap or net worth of $15.42 thousand as of September 16, 2026. Its market cap has decreased by -91.09% in one year.
Market Cap
15.42K
Enterprise Value
n/a
Revenue
50.10K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since October 22, 1998, Remedent's market cap has decreased from 207.16K to 15.42K, a decrease of -92.56%. That is a compound annual growth rate of -8.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 15.42K | 33.33% |
| Dec 19, 2025 | 11.56K | -98.91% |
| Dec 18, 2024 | 1.06M | -43.30% |
| Dec 14, 2023 | 1.87M | -43.51% |
| Dec 23, 2022 | 3.31M | 14.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hear AtLast Holdings | 194.13K |
| Wearable Health Solutions | 182.67K |
| InnerScope Hearing Technologies | 127.46K |
| KMA Holding | 42.40K |
| LifePoint | 30.63K |
| Medite Cancer Diagnostics | 8.58K |
| Medical International Technology | 8.43K |
| BioLife Sciences | 4.83K |